Artelo Biosciences ARTL
NASDAQ ARTL
$2.64 -0.01 (-0.41%)
As of: Oct 22, 2026 · 12:19 PM EDT

Artelo Biosciences (ARTL) Receivables - Other (2017 - 2018)

Updated

Artelo Biosciences' Receivables - Other was $16,484 in Q3 2018.

Analysis

Artelo Biosciences (ARTL) Receivables - Other (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.40 Bn 1,140.99 Bn 19.71 Bn
2 Johnson & Johnson 642.90 Bn 561.42 Bn 17.26 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn
4 Merck 375.88 Bn 330.26 Bn 12.21 Bn
5 Novartis Ag 302.81 Bn 266.80 Bn 11.24 Bn
6 Astrazeneca 268.58 Bn 242.27 Bn 12.86 Bn
7 Amgen 242.38 Bn 197.78 Bn 7.24 Bn
8 Gilead Sciences 193.63 Bn 167.83 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Artelo Biosciences 52,584.71 -5.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2018 16,484.00
Feb 28, 2018 1,327.00
Nov 30, 2017 767.00
API Access

Artelo Biosciences Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ARTL&period=max&api_key=YOUR_API_KEY